APA (7th ed.) Citation

Jaydeep K. Srimani, Paul M. Diderichsen, Michael J. Hanley, Karthik Venkatakrishnan, Richard Labotka, & Neeraj Gupta. (2022). Population pharmacokinetic/pharmacodynamic joint modeling of ixazomib efficacy and safety using data from the pivotal phase III TOURMALINE‐MM1 study in multiple myeloma patients. Wiley.

Chicago Style (17th ed.) Citation

Jaydeep K. Srimani, Paul M. Diderichsen, Michael J. Hanley, Karthik Venkatakrishnan, Richard Labotka, and Neeraj Gupta. Population Pharmacokinetic/pharmacodynamic Joint Modeling of Ixazomib Efficacy and Safety Using Data from the Pivotal Phase III TOURMALINE‐MM1 Study in Multiple Myeloma Patients. Wiley, 2022.

MLA (9th ed.) Citation

Jaydeep K. Srimani, et al. Population Pharmacokinetic/pharmacodynamic Joint Modeling of Ixazomib Efficacy and Safety Using Data from the Pivotal Phase III TOURMALINE‐MM1 Study in Multiple Myeloma Patients. Wiley, 2022.